D. Boral Capital Reaffirms “Buy” Rating for CervoMed (NASDAQ:CRVO)
CervoMed (NASDAQ:CRVO – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at D. Boral Capital in a research note issued to investors on Tuesday,Benzinga reports. They presently have a $10.00 price target on the stock. D. Boral Capital’s price target indicates a potential upside of 20.19% from the stock’s previous close. […]
CervoMed (NASDAQ:CRVO – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at D. Boral Capital in a research note issued to investors on Tuesday,Benzinga reports. They presently have a $10.00 price target on the stock. D. Boral Capital’s price target indicates a potential upside of 20.19% from the stock’s previous close. […]
